In Vivo Identification and Characterization of CD4⁺ Cytotoxic T Cells Induced by Virulent Brucella Abortus Infection
Overview
Authors
Affiliations
CD4(+) T cells display a variety of helper functions necessary for an efficient adaptive immune response against bacterial invaders. This work reports the in vivo identification and characterization of murine cytotoxic CD4(+) T cells (CD4(+) CTL) during Brucella abortus infection. These CD4(+) CTLs express granzyme B and exhibit immunophenotypic features consistent with fully differentiated T cells. They express CD25, CD44, CD62L ,CD43 molecules at their surface and produce IFN-γ. Moreover, these cells express neither the co-stimulatory molecule CD27 nor the memory T cell marker CD127. We show here that CD4(+) CTLs are capable of cytolytic action against Brucella-infected antigen presenting cells (APC) but not against Mycobacterium-infected APC. Cytotoxic CD4(+) T cell population appears at early stages of the infection concomitantly with high levels of IFN-γ and granzyme B expression. CD4(+) CTLs represent a so far uncharacterized immune cell sub-type triggered by early immune responses upon Brucella abortus infection.
Cytotoxic CD4+ T Cells Are Induced during Infection with Chlamydia trachomatis.
Olivas J, Nogueira C, Helble J, Starnbach M J Immunol. 2024; 213(3):328-338.
PMID: 38905023 PMC: 11279525. DOI: 10.4049/jimmunol.2300131.
Immunosuppressive Mechanisms in Brucellosis in Light of Chronic Bacterial Diseases.
Pellegrini J, Gorvel J, Memet S Microorganisms. 2022; 10(7).
PMID: 35888979 PMC: 9324529. DOI: 10.3390/microorganisms10071260.
Characterization and probiotic properties of from human breast milk.
Jamyuang C, Phoonlapdacha P, Chongviriyaphan N, Chanput W, Nitisinprasert S, Nakphaichit M 3 Biotech. 2019; 9(11):398.
PMID: 31656736 PMC: 6790201. DOI: 10.1007/s13205-019-1926-y.
Hop H, Huy T, Reyes A, Arayan L, Vu S, Min W Infect Immun. 2019; 87(11).
PMID: 31451617 PMC: 6803322. DOI: 10.1128/IAI.00431-19.
Development of new generation of vaccines for .
Gheibi A, Khanahmad H, Kashfi K, Sarmadi M, Khorramizadeh M Heliyon. 2019; 4(12):e01079.
PMID: 30603712 PMC: 6307385. DOI: 10.1016/j.heliyon.2018.e01079.